ResMed recently announced that it reached a tentative settlement agreement with the DOJ in conjunction with an investigation pertaining to ResMed’s business practices involving DME product support services. This case highlights the ongoing enforcement spotlight on DME suppliers, and the challenges of providing product support services in conjunction with DME products.
Read the full article in the September issue of Policy and Medicine Compliance Update https://complianceupdate.policymed.com/september-2019-policy-medicine-compliance-update/